Vaxigrip Junior Injektionsvätska, suspension

Country: Żvezja

Lingwa: Svediż

Sors: Läkemedelsverket (Medical Products Agency)

Ingredjent attiv:

influensavirus A/California/7/2009 (H1N1)pdm09-deriverad stam (NYMC X-179A), spjälkat virus, inaktiverat; influensavirus A/Texas/50/2012 (H3N2)-deriverad stam (NYMC X-223A), spjälkat virus, inaktiverat; influensavirus B/Massachusetts/2/2012, spjälkat virus, inaktiverat

Disponibbli minn:

Sanofi Pasteur MSD

Kodiċi ATC:

J07BB02

INN (Isem Internazzjonali):

the influenza virus A/California/7/2009 (H1N1)pdm09-derived strain (NYMC X-179A), spjälkat virus, inactivated; influenza virus, A/Texas/50/2012 (H3N2)-derived strain (NYMC X-223A), spjälkat virus, inactivated; influenza virus B/Massachusetts/2/2012, spjälkat virus, inactivated

Għamla farmaċewtika:

Injektionsvätska, suspension

Kompożizzjoni:

influensavirus A/California/7/2009 (H1N1)pdm09-deriverad stam (NYMC X-179A), spjälkat virus, inaktiverat 7,5 mikrog Aktiv substans; influensavirus A/Texas/50/2012 (H3N2)-deriverad stam (NYMC X-223A), spjälkat virus, inaktiverat 7,5 mikrog Aktiv substans; influensavirus B/Massachusetts/2/2012, spjälkat virus, inaktiverat 7,5 mikrog Aktiv substans

Tip ta 'preskrizzjoni:

Receptbelagt

Żona terapewtika:

spjälkat virus eller ytantigen

L-istatus ta 'awtorizzazzjoni:

Avregistrerad

Data ta 'l-awtorizzazzjoni:

1999-05-21